Cooperative Agreement U34DK141987
Award Date 9/5/25
Completion Date 5/31/27
Dollars Obligated $380K
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Minnesota, USA
Similar Awards
- This Cooperative Agreement award of $2,367,892 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to develop and evaluate a novel approach to mitigate the risk of diabetic ketoacidosis (DKA) in people with type 1 diabetes (T1D) and chronic kidney disease (CKD) who are taking sodium-glucose cotransporter (SGLT) inhibitor medications. The project aims...
- This $166,953 Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant was awarded to the Regents of the University of Minnesota, Office of Sponsored Projects Administration, to conduct a pilot, pragmatic, cluster-randomized clinical trial to evaluate the feasibility of an intervention to increase the use of SGLT2 inhibitor medications after...
- This federal Project Grant award of $842,633.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is focused on developing an optimal prehabilitation program for kidney transplant candidates on hemodialysis. The grant aims to elicit expert opinion to identify kidney transplant-specific prehabilitation components and strategies to enhance enrollment and adherence...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through the Diabetes, Digestive, and Kidney Diseases Extramural Research Program (CFDA 93.847), awarded a $671,986 Project Grant to Rutgers, The State University of New Jersey, to conduct research aimed at strengthening the evidence-base for medication prescribing in older adults with chronic kidney disease (CKD). The key objectives of the 4-year project are to: 1) evaluate the effectiveness of renoprotective therapies...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $314,355 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Angiotensin Therapeutics Inc., a biotechnology company located in Evanston, Illinois. The funding supports research to develop a soluble form of the enzyme Angiotensin Converting Enzyme 2 (ACE2) as a potential treatment for delayed graft function (DGF), a form of acute kidney injury that...
- This federal Project Grant award, in the amount of $531,999.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award is supporting research focused on understanding the role of alternative splicing in the proximal tubules of the kidney and its relationship to the progression of diabetic kidney disease. The research will investigate how diabetes...
- This $192,215 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program) will support a research project titled "Assessing Patient-Centric Factors and Enhancing Risk Communication to Improve Treatment Persistence in Kidney and Cardiovascular Care" at the University of California, San Francisco (UCSF). The project aims to develop an effective risk communication aid to...
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will provide $193,809 to Yale University to assess the efficacy of sodium-glucose cotransporter-2 (SGLT2) inhibitors for the treatment of acute cardiorenal syndrome. The candidate, an Instructor of Medicine (Nephrology) with 3 years of training in acute kidney injury and clinical trials,...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $200,000.00 to New York University School of Medicine to conduct a case-cohort study investigating novel determinants of risk for living kidney donors. The key objectives are to: 1) use qualitative research to inform recruitment strategies and messaging to maximize participation of...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research at New York University (NYU) to develop personalized immunosuppression regimens for kidney transplant recipients. The $847,371 award, with a project period from September 15, 2025 to July 31, 2030, will leverage a large nationwide electronic health record database to...